|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT03018886 |
|
Date of registration:
|
06/01/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Diagnosing Adult Growth Hormone Deficiency
|
|
Scientific title:
|
Diagnosis of Adult Growth Hormone Deficiency With Growth Hormone Releasing Hormone Plus Arginine Stimulation Test |
|
Date of first enrolment:
|
May 2001 |
|
Target sample size:
|
160 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03018886 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Finland
| | | | | | | |
|
Contacts
|
|
Name:
|
Esa Hamalainen, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Chief, Department of Clinical Chemistry, Helsinki University Hospital, Helsinki, Finland |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
for health patients:
1. age 20-60 years,
2. no symptoms indicative of disease.
for patients:
1. age 16-90 years
2. previous pituitary disease
3. suspicion of growth hormone deficiency
Exclusion Criteria:
for healthy controls:
1. pregnancy,
2. a known or suspected disease,
3. any symptoms indicating disease
4. use of medication
Age minimum:
16 Years
Age maximum:
80 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Growth Hormone Deficiency
|
|
Intervention(s)
|
|
Other: GHRH plus arginine test
|
|
Primary Outcome(s)
|
|
Peak serum GH (ug/l) by Immulite 2000 Xpi
[Time Frame: one year]
|
|
Secondary Outcome(s)
|
|
Serum insulin like growth hormone 1 (IGF-1) concentration
[Time Frame: one year]
|
|
Basal serum GH (ug/l) by Immulite 2000 Xpi
[Time Frame: one year]
|
|
Secondary ID(s)
|
|
203/2001 and 502/2002
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|